Rockefeller Capital Management
XFOR icon

Rockefeller Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History

Rockefeller Capital Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154 Hold
33
– – ﹤0.01% 4671
2026
Q1 		$136 Hold
33
– – ﹤0.01% 4624
2025
Q4 		$132 Hold
33
– – ﹤0.01% 4618
2025
Q3 		$113 Buy
+33
New +$85 ﹤0.01% 4372
2023
Q1 		– Sell
-33
Closed – – 3910
2022
Q4 		$0 Hold
33
– – ﹤0.01% 4254
2022
Q3 		$1K Hold
33
– – ﹤0.01% 3805
2022
Q2 		$0 Hold
33
– – ﹤0.01% 4426
2022
Q1 		$1K Hold
33
– – ﹤0.01% 3794
2021
Q4 		$2K Buy
+33
New +$4.17K ﹤0.01% 3582

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rockefeller Capital Management's XFOR Position: Q2 2026 in Review

Rockefeller Capital Management held its X4 Pharmaceuticals (XFOR) position steady in Q2 2026 at 33 shares worth $154. The position accounts for ﹤0.01% of the portfolio, ranked #4671.

Rockefeller Capital Management first reported a position in XFOR in Q4 2021 and has held it in 9 quarters since. The position peaked at $2K in Q4 2021. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Rockefeller Capital Management held 33 shares of X4 Pharmaceuticals worth $154 as of Q2 2026.
  • Rockefeller Capital Management left its X4 Pharmaceuticals share count unchanged in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4671 holding.
  • Rockefeller Capital Management first reported a position in X4 Pharmaceuticals in Q4 2021 and has held it in 9 quarters since.
  • Rockefeller Capital Management's X4 Pharmaceuticals position peaked at $2K in Q4 2021.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.